HM-1 suppresses cell metastasis via inhibition of receptor tyrosine kinase in human colorectal adenocarcinoma cell line

HM-1 suppresses cell metastasis via inhibition of receptor tyrosine kinase in human colorectal adenocarcinoma cell line

碩士 === 中國醫藥大學 === 醫學研究所 === 96 === In present study indicated that a quinazoline derivative compound (HM-1) inhibited proliferation, migration and invasion of HT-29 cells in a concentration-dependent manner. Nevertheless the related molecular mechanisms and signalling pathways of pharmacology were n...

Full description

Bibliographic Details
Main Authors:	Yi-Lin Jiang, 江羿霖
Other Authors:	鍾景光
Format:	Others
Language:	zh-TW
Published:	2008
Online Access:	http://ndltd.ncl.edu.tw/handle/46613044730790451650

Similar Items

Proliferation of Ewing sarcoma cell lines is suppressed by the receptor tyrosine kinase inhibitors gefitinib and vandetanib
by: Åman Pierre, et al.
Published: (2008-01-01)

High Levels of Receptor Tyrosine Kinases in CCM3-Deficient Cells Increase Their Susceptibility to Tyrosine Kinase Inhibition
by: Miriam Sartages, et al.
Published: (2020-12-01)

Inhibition of receptor tyrosine kinase signalling by small molecule agonist of T-cell protein tyrosine phosphatase
by: Tähtinen Siri, et al.
Published: (2010-01-01)

Expression of ron tyrosin kinase receptor on breast cancer cell lines
by: Alzeini, Khaled W. K.
Published: (2013)

RETRACTED ARTICLE: Receptor tyrosine kinase inhibitor Sunitinib and integrin antagonist peptide HM-3 show similar lipid raft dependent biphasic regulation of tumor angiogenesis and metastasis
by: Jialiang Hu, et al.
Published: (2019-08-01)

Retraction Note: Receptor tyrosine kinase inhibitor Sunitinib and integrin antagonist peptide HM-3 show similar lipid raft dependent biphasic regulation of tumor angiogenesis and metastasis
by: Jialiang Hu, et al.
Published: (2020-02-01)

HM71224, a selective Bruton’s tyrosine kinase inhibitor, attenuates the development of murine lupus
by: Yu-Yon Kim, et al.
Published: (2017-09-01)

Inhibition of uterine sarcoma cell growth through suppression of endogenous tyrosine kinase B signaling.
by: Kenichi Makino, et al.
Published: (2012-01-01)

MET and RON receptor tyrosine kinases in colorectal adenocarcinoma: molecular features as drug targets and antibody-drug conjugates for therapy
by: Hang-Ping Yao, et al.
Published: (2020-09-01)

Targeting Receptor Tyrosine Kinase on Lymphatic Endothelial Cells for the Therapy of Colon Cancer Lymph Node Metastasis
by: Robert B. Rebhun, et al.
Published: (2006-09-01)

Mechanisms of sinapinic acid and m-coumaric acidon the suppressions of invasion and metastasis inhuman colorectal adenocarcinoma cells
by: Li-Ya Tseng, et al.
Published: (2011)

Comparative tyrosine phosphoproteomics of SW480 and SW620 human colorectal adenocarcinoma cells for investigating metastasis-associated signaling pathway
by: Ting-YinLiu, et al.
Published: (2012)

Neutralizing aptamers from whole-cell SELEX inhibit the RET receptor tyrosine kinase.
by: Laura Cerchia, et al.
Published: (2005-04-01)

Neutralizing Aptamers from Whole-Cell SELEX Inhibit the RET Receptor Tyrosine Kinase
by: Cerchia Laura, et al.
Published: (2005-01-01)

Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines
by: Pietro Paolo Vitiello, et al.
Published: (2019-01-01)

Targeted Inhibition of Multiple Receptor Tyrosine Kinases in Mesothelioma
by: Wen-Bin Ou, et al.
Published: (2011-01-01)

Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells
by: Wei Zhang, et al.
Published: (2018-10-01)

Impact of Smoking and Brain Metastasis on Outcomes of Advanced EGFR Mutation Lung Adenocarcinoma Patients Treated with First Line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors.
by: Amit Jain, et al.
Published: (2015-01-01)

Receptor Tyrosine Kinase Activation in Human Carcinoma Cells
by: Fischer, Oliver Martin
Published: (2004)

Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models
by: Pinar Kanlikilicer, et al.
Published: (2017-12-01)

The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer.
by: Diana J Uribe, et al.
Published: (2017-01-01)

The receptor tyrosine kinase AXL promotes migration and invasion in colorectal cancer
by: Uribe, Diana J., et al.
Published: (2017)

Impact of clinicopathologic features on leptomeningeal metastasis from lung adenocarcinoma and treatment efficacy with epidermal growth factor receptor tyrosine kinase inhibitor
by: Byoung Soo Kwon, et al.
Published: (2020-02-01)

Retraction: Neutralizing Aptamers from Whole-Cell SELEX Inhibit the RET Receptor Tyrosine Kinase.
Published: (2015-07-01)

Ron Receptor Tyrosine Kinase Activation Confers Resistance to Tamoxifen in Breast Cancer Cell Lines
by: Rebecca J. McClaine, et al.
Published: (2010-08-01)

A small molecule agonist of EphA2 receptor tyrosine kinase inhibits tumor cell migration in vitro and prostate cancer metastasis in vivo.
by: Aaron Petty, et al.
Published: (2012-01-01)

Colorectal Adenocarcinoma Metastasis to the Tongue
by: Kurren S. Gill, et al.
Published: (2015-01-01)

Cisplatin and ultra-violet-C synergistically down-regulate receptor tyrosine kinases in human colorectal cancer cells
by: Kawaguchi Junji, et al.
Published: (2012-07-01)

A tyrosine kinase profile of bladder cancer cell lines
by: Shi-An Chen, et al.
Published: (1999)

The role of the receptor tyrosine kinase RON in inhibiting HIV transcription
by: Cantor, Amanda
Published: (2015)

Bax/Tubulin/Epithelial-Mesenchymal Pathways Determine the Efficacy of Silybin Analog HM015k in Colorectal Cancer Cell Growth and Metastasis
by: Haneen Amawi, et al.
Published: (2018-05-01)

The Role of Receptor Tyrosine Kinases in Lassa Virus Cell Entry
by: Chiara Fedeli, et al.
Published: (2020-08-01)

Functional fluorescence imaging of receptor tyrosine kinase activity in cells
by: Reynolds, Andrew Robert
Published: (2002)

Inhibition of tyrosine kinase receptor Tie2 reverts HCV-induced hepatic stellate cell activation.
by: Samuel Martín-Vílchez, et al.
Published: (2014-01-01)

The percentage of Epidermal Growth Factor Receptor (EGFR)-mutated neoplastic cells correlates to response to tyrosine kinase inhibitors in lung adenocarcinoma.
by: Dario de Biase, et al.
Published: (2017-01-01)

Metastatic Squamous Cell Carcinoma from Lung Adenocarcinoma after Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy
by: Hyung Kyu Park, et al.
Published: (2017-07-01)

The SYK tyrosine kinase suppresses autolysosome biogenesis via activation of mTORC1 in pancreatic cancer cell lines
by: Hua, Kevin Lee
Published: (2019)

Silencing of Receptor Tyrosine Kinase ROR1 Inhibits Tumor-Cell Proliferation via PI3K/AKT/mTOR Signaling Pathway in Lung Adenocarcinoma.
by: Yanchun Liu, et al.
Published: (2015-01-01)

Tyrosine Kinase Receptors in Oncology
by: Jorge Esteban-Villarrubia, et al.
Published: (2020-11-01)

Profiling tyrosine kinases in human liver tissues and HCC cell lines
by: Wu, Keh-Ming, et al.
Published: (1997)